Analyst Insights - Digital Health Posts
Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights". Click on the premium insights link below to filter for just the premium content.
AI Accelerating COVID-19 Drug Discovery
31st March 2020 – As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever before.
AI Impact on the Teleradiology Market: The Signify View
26th March 2020 – This week UK telerad firm Medica announced a strategic relationship with Qure.ai, a supplier of AI solutions for radiology. Here’s our take on the deal and the Signify View on how AI will be used throughout the teleradiology market.
Signify Premium Insights: TeraRecon Acquired by SymphonyAI
6th March 2020 – TeraRecon has announced it had signed an agreement to be acquired by the SymphonyAI Group. Here’s the Signify View
Capital Funding for Diagnostic Ultrasound Companies Normalises After 2018 Spike
27th February 2020 – Capital investment in diagnostic ultrasound companies reached a record breaking $390 million in 2018. Here’s our analysis of how this developed in 2019.
The Many Faces of AI in Clinical Trials
27th February 2020 – AI is being applied in several aspects for the clinical trial process today. In this article, we will present some of the technologies using AI and machine learning in the clinical trial space and take a closer look at the clinical trial ecosystem.